SCHEMBL20200121

SCHEMBL20200121

Cc1ncc(F)c2c1ncn2C

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AHCY P23526 9/20 0.33
▸ IKBKB O14920 5/20 0.32
▸ CHUK O15111 4/20 0.32
▸ ADORA2A P29274 2/20 0.32
▸ ADORA1 P30542 2/20 0.32
▸ GDA Q9Y2T3 2/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ NTSR1 P30989 1/20 0.31
▸ MC3R P41968 1/20 0.31
▸ NOTUM Q6P988 1/20 0.31
▸ SIRT3 Q9NTG7 1/20 0.31
▸ NR2E1 Q9Y466 1/20 0.31
▸ DPP4 P27487 1/20 0.31
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15186166 0.79 AHCY (0.51) AHCYIKBKBADORA2AADORA1ADORA2B
SCHEMBL21338966 0.77 AHCY (0.31) AHCYIKBKBCHUK
SCHEMBL20200120 0.73 APLNR (0.36) AHCY
SCHEMBL27285050 0.71 ADORA2A (0.35) IKBKBCHUKADORA2AADORA1GDA
SCHEMBL25472935 0.71 ADORA1 (0.44) ADORA2AADORA1
SCHEMBL30206029 0.69 IKBKB (0.33) IKBKBCHUKADORA2AADORA1GDA
SCHEMBL12256556 0.69 IKBKB (0.37) IKBKBCHUKADORA2AADORA1POLB
SCHEMBL26536287 0.68 F2RL1 (0.37) —
SCHEMBL27404282 0.64 GDA (0.35) ADORA2AADORA1GDAPIK3CDPOLB
SCHEMBL9601945 0.64 CASP3 (0.43) IKBKBCHUKPIK3CDDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 — — EP disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 — — WO disclosed
Send feedback